Caitong International Asset Management Co., LTD Biocryst Pharmaceuticals Inc Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 10 shares of BCRX stock, worth $87. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10Holding current value
$87% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BCRX
# of Institutions
294Shares Held
177MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$190 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$175 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$78.2 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$76.2 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$68.4 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.63B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...